Patterns of huntingtin protein aggregation and cortical neuronal loss suggest early involvement of corticostriatal pathways in Huntington's disease. However, theories of pathogenesis of chorea rely on the motor cortices being intact. The motor cortices have not previously been studied at a cellular level in Huntington's disease. We analyzed the neuronal number in the caudate, putamen, and three motor cortical areas in five cases of Huntington's disease and five controls. For each motor cortical region the total neuronal number, number of interneurons, and number of SMI32 immunopositive pyramidal neurons were quantified using previously published techniques and any relationship between cell loss and severity or duration of chorea was examined. The results showed a loss of long projecting SMI32 immunopositive pyramidal neurons in the primary motor cortex with associated morphological changes and suggest a loss of short projecting pyramidal neurons in the premotor cortex. Degeneration in the primary motor cortex correlated with subcortical degeneration. These findings indicate pyramidal cell involvement in Huntington's disease and implicate the degeneration of corticostriatal pathways in the production of chorea.
INTRODUCTION
Huntington's disease (HD) is an autosomal dominant movement disorder generally thought to be caused by substantial neurodegeneration concentrating in subcortical basal ganglia circuits (Koroshetz et al., 1992; Vonsattel & DiFiglia, 1998) . However, there is mounting evidence that the cortex plays a primary role in the generation of the clinical symptoms due to intrinsic pathological events. The clinical evidence includes transcranial magnetic stimulation and peripherally evoked cortical potentials which show an intrinsic change in motor cortices (Berardelli et al., 1999; Priori et al., 2000) . Studies show that cortical changes occur at symptom onset and worsen with symptom duration (Aylward et al., 1998; Backman et al., 1997; Bartenstein et al., 1997; Garrett et al., 1998; HahnBarma et al., 1998; Jenkins et al., 1993; Kuwert et al., 1990; Sax et al., 1996; Storey & Beal, 1993; Weeks et al., 1997) and that chorea is a rare consequence of isolated striatal lesions in humans (Bhatia & Marsden, 1994) . These studies suggest that both cortical and subcortical changes underlie the clinical signs and symptoms of HD.
The genetic defect in HD involves an expanded trinucleotide repeat (CAG) on the short arm of chromosome 4 in the gene coding the huntingtin protein (Huntington's Disease Collaborative Research Group, 1993; Vonsattel & DiFiglia, 1998) . Abnormal huntingtin aggregates within the neuronal cytoplasm, translocating to neuronal nuclei with time to form intranuclear inclusions (Sieradzan & Mann, 2001 ). The greater frequency of intranuclear inclusions in the cortex than in the striatum (DiFiglia et al., 1995 (DiFiglia et al., , 1997 Gutekunst et al., 2000) , the predilection of these inclusions for the corticostriatal projection neurons of layers V-VI (Sapp et al., 1999; Sieradzan & Mann, 2001) , and the presence of abundant neuropil huntingtin aggregates in the cerebral cortex in presymptomatic HD (Sieradzan & Mann, 2001) provide convincing evidence for the early pathological involvement of corticostriatal pathways. CAG repeat numbers correlate with the density of cortical inclusions (Becher et al., 1998) and the rate of cortical atrophy (Halliday et al., 1998) 
